Literature DB >> 33527450

Genetic characterisation of adult primary pleomorphic uterine rhabdomyosarcoma and comparison with uterine carcinosarcoma.

Charles W Ashley1, Arnaud Da Cruz Paula1, Lorenzo Ferrando2,3, Rodrigo Gularte-Mérida1,2, Ana P M Sebastiao2, David N Brown2, Andrea M Gazzo2, Fresia Pareja2, Anthe Stylianou1, Nadeem R Abu-Rustum1, Jorge S Reis-Filho2, Darya Buehler4, Paul Weisman4, Sarah Chiang2, Britta Weigelt2.   

Abstract

AIMS: To characterise the genetic alterations in adult primary uterine rhabdomyosarcomas (uRMSs) and to investigate whether these tumours are genetically distinct from uterine carcinosarcomas (UCSs). METHODS AND
RESULTS: Three tumours originally diagnosed as primary adult pleomorphic uRMS were subjected to massively parallel sequencing targeting 468 cancer-related genes and RNA-sequencing. Mutational profiles were compared with those of UCSs (n = 57) obtained from The Cancer Genome Atlas. Sequencing data analyses were performed using validated bioinformatic approaches. Pathogenic TP53 mutations and high levels of genomic instability were detected in the three cases. uRMS1 harboured a likely pathogenic YTHDF2-FOXR1 fusion. uRMS2 harboured a PPP2R1A hotspot mutation and amplification of multiple genes, including WHSC1L1, FGFR1, MDM2, and CCNE1, whereas uRMS3 harboured an FBXW7 hotspot mutation and an ANKRD11 homozygous deletion. Hierarchical clustering of somatic mutations and copy number alterations revealed that these tumours initially diagnosed as pleomorphic uRMSs and UCSs were similar. Subsequent comprehensive pathological re-review of the three uRMSs revealed previously unidentified minute pan-cytokeratin-positive atypical glands in one case (uRMS3), favouring its reclassification as UCS with extensive rhabdomyosarcomatous overgrowth.
CONCLUSIONS: Adult pleomorphic uRMSs harbour TP53 mutations and high levels of copy number alterations. Our findings underscore the challenge in discriminating between uRMS and UCS with rhabdomyosarcomatous differentiation.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  carcinosarcoma; fusion gene; molecular genetics; uterine rhabdomyosarcoma

Mesh:

Year:  2021        PMID: 33527450      PMCID: PMC8286280          DOI: 10.1111/his.14346

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   7.778


  57 in total

1.  Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis.

Authors:  Michelle Reid-Nicholson; Pratibha Iyengar; Amanda J Hummer; Irina Linkov; Marina Asher; Robert A Soslow
Journal:  Mod Pathol       Date:  2006-04-28       Impact factor: 7.842

2.  Indel variant analysis of short-read sequencing data with Scalpel.

Authors:  Han Fang; Ewa A Bergmann; Kanika Arora; Vladimir Vacic; Michael C Zody; Ivan Iossifov; Jason A O'Rawe; Yiyang Wu; Laura T Jimenez Barron; Julie Rosenbaum; Michael Ronemus; Yoon-Ha Lee; Zihua Wang; Esra Dikoglu; Vaidehi Jobanputra; Gholson J Lyon; Michael Wigler; Michael C Schatz; Giuseppe Narzisi
Journal:  Nat Protoc       Date:  2016-11-17       Impact factor: 13.491

3.  The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers.

Authors:  Britta Weigelt; Rui Bi; Rahul Kumar; Pedro Blecua; Diana L Mandelker; Felipe C Geyer; Fresia Pareja; Paul A James; Fergus J Couch; Diana M Eccles; Fiona Blows; Paul Pharoah; Anqi Li; Pier Selenica; Raymond S Lim; Gowtham Jayakumaran; Nic Waddell; Ronglai Shen; Larry Norton; Hannah Y Wen; Simon N Powell; Nadeem Riaz; Mark E Robson; Jorge S Reis-Filho; Georgia Chenevix-Trench
Journal:  J Natl Cancer Inst       Date:  2018-09-01       Impact factor: 13.506

4.  Chromosomal imbalances in pleomorphic rhabdomyosarcomas and identification of the alveolar rhabdomyosarcoma-associated PAX3-FOXO1A fusion gene in one case.

Authors:  Anthony Gordon; Aidan McManus; John Anderson; Cyril Fisher; Syuiti Abe; Takayuki Nojima; Kathy Pritchard-Jones; Janet Shipley
Journal:  Cancer Genet Cytogenet       Date:  2003-01-01

5.  Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.

Authors:  Elisabetta Kuhn; Ren-Chin Wu; Bin Guan; Gang Wu; Jinghui Zhang; Yue Wang; Lei Song; Xiguo Yuan; Lei Wei; Richard B S Roden; Kuan-Tin Kuo; Kentaro Nakayama; Blaise Clarke; Patricia Shaw; Narciso Olvera; Robert J Kurman; Douglas A Levine; Tian-Li Wang; Ie-Ming Shih
Journal:  J Natl Cancer Inst       Date:  2012-08-23       Impact factor: 13.506

6.  Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs.

Authors:  Christopher T Saunders; Wendy S W Wong; Sajani Swamy; Jennifer Becq; Lisa J Murray; R Keira Cheetham
Journal:  Bioinformatics       Date:  2012-05-10       Impact factor: 6.937

7.  Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers.

Authors:  Simone Hettmer; Natasha M Archer; Gino R Somers; Ana Novokmet; Amy J Wagers; Lisa Diller; Carlos Rodriguez-Galindo; Lisa A Teot; David Malkin
Journal:  Cancer       Date:  2013-12-30       Impact factor: 6.860

8.  Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes.

Authors:  Siân Jones; Nicolas Stransky; Christine L McCord; Ethan Cerami; James Lagowski; Devon Kelly; Samuel V Angiuoli; Mark Sausen; Lisa Kann; Manish Shukla; Rosemary Makar; Laura D Wood; Luis A Diaz; Christoph Lengauer; Victor E Velculescu
Journal:  Nat Commun       Date:  2014-09-19       Impact factor: 14.919

9.  Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia.

Authors:  Jasmin Paris; Marcos Morgan; Joana Campos; Gary J Spencer; Alena Shmakova; Ivayla Ivanova; Christopher Mapperley; Hannah Lawson; David A Wotherspoon; Catarina Sepulveda; Milica Vukovic; Lewis Allen; Annika Sarapuu; Andrea Tavosanis; Amelie V Guitart; Arnaud Villacreces; Christian Much; Junho Choe; Ali Azar; Louie N van de Lagemaat; Douglas Vernimmen; Ali Nehme; Frederic Mazurier; Tim C P Somervaille; Richard I Gregory; Dónal O'Carroll; Kamil R Kranc
Journal:  Cell Stem Cell       Date:  2019-04-25       Impact factor: 24.633

10.  Genome-wide somatic variant calling using localized colored de Bruijn graphs.

Authors:  Giuseppe Narzisi; André Corvelo; Kanika Arora; Ewa A Bergmann; Minita Shah; Rajeeva Musunuri; Anne-Katrin Emde; Nicolas Robine; Vladimir Vacic; Michael C Zody
Journal:  Commun Biol       Date:  2018-03-22
View more
  1 in total

1.  Case Report: A PD-L1-Positive Patient With Pleomorphic Rhabdomyosarcoma Achieving an Impressive Response to Immunotherapy.

Authors:  Jiayong Liu; Peijie Liu; Fuyu Gong; Youhui Tian; Xiaochen Zhao
Journal:  Front Immunol       Date:  2022-03-17       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.